CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
2022 · Journal of Experimental & Clinical Cancer Research · 587 citations
https://doi.org/10.1186/s13046-022-02327-z
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
638
Citations
2
h-index
2
i10-index
Kevin Pan is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Nitric Oxide and Endothelin Effects & Immune Cell Function and Interaction & CAR-T cell therapy research. The author has an h-index of 2, co-authored 2 publications.
Click to start Chat